Regulation of Hepatocellular Fatty Acid Uptake in Mouse Models of Fatty Liver Disease with and without Functional Leptin Signaling: Roles of NfKB and SREBP-1C and the Effects of Spexin

Jasmine F. Ge; J. L. Walewski; D. Anglade; P. D. Berk

doi:10.1055/s-0036-1597248

Seminars in Liver Disease, Table of Contents

Semin Liver Dis 2016; 36(04): 360-372
DOI: 10.1055/s-0036-1597248

Review Article

Thieme Medical Publishers 333 Seventh Avenue, New York, NY 10001, USA.

Regulation of Hepatocellular Fatty Acid Uptake in Mouse Models of Fatty Liver Disease with and without Functional Leptin Signaling: Roles of NfKB and SREBP-1C and the Effects of Spexin

Jasmine F. Ge

¹Divisions of Digestive and Liver Disease, and Preventive Medicine, Department of Medicine, Columbia College of Physicians and Surgeons, New York, New York

,

J. L. Walewski

¹Divisions of Digestive and Liver Disease, and Preventive Medicine, Department of Medicine, Columbia College of Physicians and Surgeons, New York, New York

,

D. Anglade

¹Divisions of Digestive and Liver Disease, and Preventive Medicine, Department of Medicine, Columbia College of Physicians and Surgeons, New York, New York

,

P. D. Berk

¹Divisions of Digestive and Liver Disease, and Preventive Medicine, Department of Medicine, Columbia College of Physicians and Surgeons, New York, New York

› Author Affiliations

Abstract

The processes causing increased hepatic triglycerides (TGs) in mouse models of hepatic steatosis (HS) due to high fat diet (HFD)-induced obesity (DIO), EtOH consumption, or obesity mutations (ob/ob, db/db) are uncertain. This report summarizes two studies. Study 1 focused on regulation by five transcription factors (TFs) (NfKb, Srebp-lc, AMPK, PPARα, PPARγ) of seven, much-studied hepatic long-chain fatty acid (LCFA) transporters (FABPpm, CD36, FATPl, FATP2, FATP4, FATP5, & Caveolin-1 [CAV-1]), and expression of genes for enzymes of LCFA synthesis (SCD-1, FASN) in mice with HS from various causes. Study 2 examined the effects of spexin, a novel adipokine, on obesity, type 2 diabetes mellitus (T2DM), and HS in these mice. Study 1 showed that: (1) processes underlying HS differed in mice with normal leptin signaling (DIO, EtoH-fed) versus those without it (ob/ob, db/db). Increased hepatocellular LCFA uptake was the principal cause of HS in the former, but increased hepatocellular LCFA synthesis predominated in the latter. (2) Expression of individual transporters was variable in the HS models studied, but strong correlations between TF expression and mean expression of four transporter genes across multiple HS models suggested regulatory interaction, and support the postulate that complexes of several different transporters mediate hepatic LCFA uptake. Study 2 indicated (1) that obese DIO mice often also have T2DM and/or nonalcoholic fatty liver disease (NAFLD); (2) confirmed that spexin treatment caused weight loss in DIO mice; (3) in DIO mice with T2DM, spexin also improved glucose tolerance, decreasing insulin resistance and HbAlc. Incubation with spexin directly inhibited LCFA uptake by hepatocytes isolated from DIO mice with HS/NAFLD by ≤70%. Spexin treatment in vivo for 4 weeks reduced hepatic lipids by 60%, and reduced serum alanine and aspartate aminotransferases. These studies in mice with DIO, T2DM, and HS/NAFLD suggest spexin may be an effective treatment for all three conditions.

Keywords

obesity - diabetes - hepatic steatosis - fatty acids - fatty acid uptake - spexin

Full Text

References

References
1 Berk PD. Regulatable fatty acid transport mechanisms are central to the pathophysiology of obesity, fatty liver, and metabolic syndrome. Hepatology 2008; 48 (5) 1362-1376
2 Berk PD, Stump DD. Mechanisms of cellular uptake of long chain free fatty acids. Mol Cell Biochem 1999; 192 (1-2) 17-31
3 Petrescu O, Fan X, Gentileschi P , et al. Long-chain fatty acid uptake is upregulated in omental adipocytes from patients undergoing bariatric surgery for obesity. Int J Obes 2005; 29 (2) 196-203
4 Stump DD, Fan X, Berk PD. Oleic acid uptake and binding by rat adipocytes define dual pathways for cellular fatty acid uptake. J Lipid Res 2001; 42 (4) 509-520
5 Stump DD, Nunes RM, Sorrentino D, Isola LM, Berk PD. Characteristics of oleate binding to liver plasma membranes and its uptake by isolated hepatocytes. J Hepatol 1992; 16 (3) 304-315
6 Ge F, Zhou S, Hu C, Lobdell IV H, Berk PD. Insulin- and leptin-regulated fatty acid uptake plays a key causal role in hepatic steatosis in mice with intact leptin signaling but not in ob/ob or db/db mice. Am J Physiol Gastrointest Liver Physiol 2010; 299 (4) G855-G866
7 Walewski JL, Ge F, Lobdell IV H , et al. Spexin is a novel human peptide that reduces adipocyte uptake of long chain fatty acids and causes weight loss in rodents with diet-induced obesity. Obesity (Silver Spring) 2014; 22 (7) 1643-1652
8 Bahary N, Leibel RL, Joseph L, Friedman JM. Molecular mapping of the mouse db mutation. Proc Natl Acad Sci U S A 1990; 87 (21) 8642-8646
9 Stremmel W, Berk PD. Hepatocellular influx of [¹⁴C]oleate reflects membrane transport rather than intracellular metabolism or binding. Proc Natl Acad Sci U S A 1986; 83 (10) 3086-3090
10 Stremmel W, Strohmeyer G, Berk PD. Hepatocellular uptake of oleate is energy dependent, sodium linked, and inhibited by an antibody to a hepatocyte plasma membrane fatty acid binding protein. Proc Natl Acad Sci U S A 1986; 83 (11) 3584-3588
11 SAAMII user guide. Seattle, WA: SAAM Institute; 1998
12 Folch J, Lees M, Sloane Stanley GH. A simple method for the isolation and purification of total lipides from animal tissues. J Biol Chem 1957; 226 (1) 497-509
13 Spector AA, Fletcher JE, Ashbrook JD. Analysis of long-chain free fatty acid binding to bovine serum albumin by determination of stepwise equilibrium constants. Biochemistry 1971; 10 (17) 3229-3232
14 Wosilait WD, Nagy P. A method of computing drug distribution in plasma using stepwise association constants: clofibrate acid as an illustrative example. Comput Programs Biomed 1976; 6 (3) 142-148
15 Kleiner DE, Brunt EM, Van Natta M , et al; Nonalcoholic Steatohepatitis Clinical Research Network. Design and validation of a histological scoring system for nonalcoholic fatty liver disease. Hepatology 2005; 41 (6) 1313-1321
16 Stremmel W, Staffer S, Wannhoff A, Pathil A, Chamulitrat W. Plasma membrane phospholipase A2 controls hepatocellular fatty acid uptake and is responsive to pharmacological modulation: implications for nonalcoholic steatohepatitis. FASEB J 2014; 28 (7) 3159-3170
17 Lenz LS, Marx J, Chamulitrat W , et al. Adipocyte-specific inactivation of Acyl-CoA synthetase fatty acid transport protein 4 (Fatp4) in mice causes adipose hypertrophy and alterations in metabolism of complex lipids under high fat diet. J Biol Chem 2011; 286 (41) 35578-35587
18 Digel M, Ehehalt R, Stremmel W, Füllekrug J. Acyl-CoA synthetases: fatty acid uptake and metabolic channeling. Mol Cell Biochem 2009; 326 (1-2) 23-28
19 Ehehalt R, Füllekrug J, Pohl J, Ring A, Herrmann T, Stremmel W. Translocation of long chain fatty acids across the plasma membrane—lipid rafts and fatty acid transport proteins. Mol Cell Biochem 2006; 284 (1-2) 135-140
20 Hall AM, Wiczer BM, Herrmann T, Stremmel W, Bernlohr DA. Enzymatic properties of purified murine fatty acid transport protein 4 and analysis of acyl-CoA synthetase activities in tissues from FATP4 null mice. J Biol Chem 2005; 280 (12) 11948-11954
21 Pohl J, Ring A, Ehehalt R, Herrmann T, Stremmel W. New concepts of cellular fatty acid uptake: role of fatty acid transport proteins and of caveolae. Proc Nutr Soc 2004; 63 (2) 259-262
22 Stremmel W, Pohl L, Ring A, Herrmann T. A new concept of cellular uptake and intracellular trafficking of long-chain fatty acids. Lipids 2001; 36 (9) 981-989
23 Herrmann T, Buchkremer F, Gosch I, Hall AM, Bernlohr DA, Stremmel W. Mouse fatty acid transport protein 4 (FATP4): characterization of the gene and functional assessment as a very long chain acyl-CoA synthetase. Gene 2001; 270 (1-2) 31-40
24 Walewski JL, Ge F, Gagner M , et al. Adipocyte accumulation of long-chain fatty acids in obesity is multifactorial, resulting from increased fatty acid uptake and decreased activity of genes involved in fat utilization. Obes Surg 2010; 20 (1) 93-107
25 Kamp F, Zakim D, Zhang F, Noy N, Hamilton JA. Fatty acid flip-flop in phospholipid bilayers is extremely fast. Biochemistry 1995; 34 (37) 11928-11937
26 Nakamura MT, Cheon Y, Li Y, Nara TY. Mechanisms of regulation of gene expression by fatty acids. Lipids 2004; 39 (11) 1077-1083
27 Stremmel W, Kochwa S, Berk PD. Studies of oleate binding to rat liver plasma membranes. Biochem Biophys Res Commun 1983; 112 (1) 88-95
28 Stremmel W, Strohmeyer G, Borchard F, Kochwa S, Berk PD. Isolation and partial characterization of a fatty acid binding protein in rat liver plasma membranes. Proc Natl Acad Sci U S A 1985; 82 (1) 4-8
29 Schwieterman W, Sorrentino D, Potter BJ , et al. Uptake of oleate by isolated rat adipocytes is mediated by a 40-kDa plasma membrane fatty acid binding protein closely related to that in liver and gut. Proc Natl Acad Sci U S A 1988; 85 (2) 359-363
30 Potter BJ, Stump D, Schwieterman W , et al. Isolation and partial characterization of plasma membrane fatty acid binding proteins from myocardium and adipose tissue and their relationship to analogous proteins in liver and gut. Biochem Biophys Res Commun 1987; 148 (3) 1370-1376
31 Stremmel W, Lotz G, Strohmeyer G, Berk PD. Identification, isolation, and partial characterization of a fatty acid binding protein from rat jejunal microvillous membranes. J Clin Invest 1985; 75 (3) 1068-1076
32 Sorrentino D, Stump D, Potter BJ , et al. Oleate uptake by cardiac myocytes is carrier mediated and involves a 40-kD plasma membrane fatty acid binding protein similar to that in liver, adipose tissue, and gut. J Clin Invest 1988; 82 (3) 928-935
33 Berk PD, Wada H, Horio Y , et al. Plasma membrane fatty acid-binding protein and mitochondrial glutamic-oxaloacetic transaminase of rat liver are related. Proc Natl Acad Sci U S A 1990; 87 (9) 3484-3488
34 Stump DD, Zhou SL, Berk PD. Comparison of plasma membrane FABP and mitochondrial isoform of aspartate aminotransferase from rat liver. Am J Physiol 1993; 265 (5 Pt 1) G894-G902
35 Zhou SL, Stump D, Kiang CL, Isola LM, Berk PD. Mitochondrial aspartate aminotransferase expressed on the surface of 3T3-L1 adipocytes mediates saturable fatty acid uptake. Proc Soc Exp Biol Med 1995; 208 (3) 263-270
36 Isola LM, Zhou S-L, Kiang C-L, Stump DD, Bradbury MW, Berk PD. 3T3 fibroblasts transfected with a cDNA for mitochondrial aspartate aminotransferase express plasma membrane fatty acid-binding protein and saturable fatty acid uptake. Proc Natl Acad Sci U S A 1995; 92 (21) 9866-9870
37 Zhou SL, Gordon RE, Bradbury M, Stump D, Kiang CL, Berk PD. Ethanol up-regulates fatty acid uptake and plasma membrane expression and export of mitochondrial aspartate aminotransferase in HepG2 cells. Hepatology 1998; 27 (4) 1064-1074
38 Bradbury MW, Berk PD. Mitochondrial aspartate aminotransferase: direction of a single protein with two distinct functions to two subcellular sites does not require alternative splicing of the mRNA. Biochem J 2000; 345 (Pt 3) 423-427
39 Trigatti BL, Anderson RG, Gerber GE. Identification of caveolin-1 as a fatty acid binding protein. Biochem Biophys Res Commun 1999; 255 (1) 34-39
40 Abumrad NA, el-Maghrabi MR, Amri EZ, Lopez E, Grimaldi PA. Cloning of a rat adipocyte membrane protein implicated in binding or transport of long-chain fatty acids that is induced during preadipocyte differentiation. Homology with human CD36. J Biol Chem 1993; 268 (24) 17665-17668
41 Hirsch D, Stahl A, Lodish HF. A family of fatty acid transporters conserved from mycobacterium to man. Proc Natl Acad Sci U S A 1998; 95 (15) 8625-8629
42 Schaffer JE, Lodish HF. Expression cloning and characterization of a novel adipocyte long chain fatty acid transport protein. Cell 1994; 79 (3) 427-436
43 Stahl A, Gimeno RE, Tartaglia LA, Lodish HF. Fatty acid transport proteins: a current view of a growing family. Trends Endocrinol Metab 2001; 12 (6) 266-273
44 Sorrentino D, Robinson RB, Kiang CL, Berk PD. At physiologic albumin/oleate concentrations oleate uptake by isolated hepatocytes, cardiac myocytes, and adipocytes is a saturable function of the unbound oleate concentration. Uptake kinetics are consistent with the conventional theory. J Clin Invest 1989; 84 (4) 1325-1333
45 Sorrentino D, Stump DD, Van Ness K , et al. Oleate uptake by isolated hepatocytes and the perfused rat liver is competitively inhibited by palmitate. Am J Physiol 1996; 270 (2 Pt 1) G385-G392
46 Spector AA, Steinberg D, Tanaka A. Uptake of free fatty acids by Ehrlich ascites tumor cells. J Biol Chem 1965; 240: 1032-1041
47 Berk PD, Zhou SL, Kiang CL, Stump D, Bradbury M, Isola LM. Uptake of long chain free fatty acids is selectively up-regulated in adipocytes of Zucker rats with genetic obesity and non-insulin-dependent diabetes mellitus. J Biol Chem 1997; 272 (13) 8830-8835
48 Berk PD, Zhou S, Kiang C, Stump DD, Fan X, Bradbury MW. Selective up-regulation of fatty acid uptake by adipocytes characterizes both genetic and diet-induced obesity in rodents. J Biol Chem 1999; 274 (40) 28626-28631
49 Ge F, Walewski JL, Torghabeh MH , et al. Facilitated long chain fatty acid uptake by adipocytes remains upregulated relative to BMI for more than a year after major bariatric surgical weight loss. Obesity (Silver Spring) 2016; 24 (1) 113-122
50 Ge F, Hu C, Hyodo E , et al. Cardiomyocyte triglyceride accumulation and reduced ventricular function in mice with obesity reflect increased long chain fatty acid uptake and de novo fatty acid synthesis. J Obes 2012; 2012: 205648
51 Hu C, Ge F, Hyodo E , et al. Chronic ethanol consumption increases cardiomyocyte fatty acid uptake and decreases ventricular contractile function in C57BL/6J mice. J Mol Cell Cardiol 2013; 59: 30-40
52 Angin Y, Steinbusch LK, Simons PJ , et al. CD36 inhibition prevents lipid accumulation and contractile dysfunction in rat cardiomyocytes. Biochem J 2012; 448 (1) 43-53
53 Harvey WJ. Works of William Harvey. London, UK: Sydenham Society; 1628
54 Verna EC, Berk PD. Role of fatty acids in the pathogenesis of obesity and fatty liver: impact of bariatric surgery. Semin Liver Dis 2008; 28 (4) 407-426
55 Berk PD, Verna EC. Nonalcoholic fatty liver disease: lipids and insulin resistance. Clin Liver Dis 2016; 20 (2) 245-262
56 Ehehalt R, Sparla R, Kulaksiz H, Herrmann T, Füllekrug J, Stremmel W. Uptake of long chain fatty acids is regulated by dynamic interaction of FAT/CD36 with cholesterol/sphingolipid enriched microdomains (lipid rafts). BMC Cell Biol 2008; 9: 45
57 Krammer J, Digel M, Ehehalt F, Stremmel W, Füllekrug J, Ehehalt R. Overexpression of CD36 and acyl-CoA synthetases FATP2, FATP4 and ACSL1 increases fatty acid uptake in human hepatoma cells. Int J Med Sci 2011; 8 (7) 599-614
58 Seeßle J, Liebisch G, Schmitz G, Stremmel W, Chamulitrat W. Palmitate activation by fatty acid transport protein 4 as a model system for hepatocellular apoptosis and steatosis. Biochim Biophys Acta 2015; 1851 (5) 549-565
59 Schneider H, Staudacher S, Poppelreuther M, Stremmel W, Ehehalt R, Füllekrug J. Protein mediated fatty acid uptake: synergy between CD36/FAT-facilitated transport and acyl-CoA synthetase-driven metabolism. Arch Biochem Biophys 2014; 546: 8-18
60 Deng X, Wang J, Jiao L , et al. iPLA2β deficiency attenuates obesity and hepatic steatosis in ob/ob mice through hepatic fatty-acyl phospholipid remodeling. Biochim Biophys Acta 2016; 1861 (5) 449-461
61 Mirabeau O, Perlas E, Severini C , et al. Identification of novel peptide hormones in the human proteome by hidden Markov model screening. Genome Res 2007; 17 (3) 320-327
62 Ge F, Lobdell IV H, Zhou S, Hu C, Berk PD. Digital analysis of hepatic sections in mice accurately quantitates triglycerides and selected properties of lipid droplets. Exp Biol Med (Maywood) 2010; 235 (11) 1282-1286